Increased VEGF expression is significantly associated with angiogenesis and advanced-stage HCC [16]; therefore, the use of VEGFR signaling pathway inhibitors represents a rational and attractive approach to control HCC. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.